import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰åœ–æ›¸é¤¨ (2026 æ——è‰¦æœ€çµ‚æ¥µé‡æ•´åˆç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

# åˆå§‹åŒ– session_state ç”¨æ–¼è¯å‹•èˆ‡æŒä¹…åŒ–
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = "ğŸ“š RUBY (ENGOT-EN6)"

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === UI é«˜å°æ¯”åº¦èˆ‡è¦–è¦ºæ•‘æ´ === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9; color: #1A1A1A;
        font-size: 19px !important; line-height: 1.1;
    }

    .main-title {
        font-size: 32px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* åœ–ä¸€ä¿®å¾©ï¼šå¤§éšæ®µ Header æ·±è‰²æ¼¸å±¤ï¼Œç¢ºä¿ç™½è‰²æ–‡å­—æ¸…æ™° */
    .big-stage-card {
        border-radius: 10px; padding: 0px; box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        border: 2px solid transparent; background: white; margin-bottom: 4px; overflow: hidden; height: auto !important;
    }
    .big-stage-header {
        font-size: 18px !important; font-weight: 900; color: white !important;
        padding: 8px; text-align: center; text-shadow: 1px 1px 2px rgba(0,0,0,0.3);
    }

    /* éšæ®µé…è‰²é£½å’ŒåŒ– */
    .card-p-tx { border-color: #1B5E20; }
    .header-p-tx { background: linear-gradient(135deg, #2E7D32, #1B5E20); } /* åˆæ²»: æ·±ç¶  */
    .card-p-mt { border-color: #0D47A1; }
    .header-p-mt { background: linear-gradient(135deg, #1565C0, #0D47A1); } /* ç¶­æŒ: æ·±è— */
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #EF6C00, #BF360C); } /* å¾©ç™¼: æ·±æ©˜ç´… */
    .card-r-mt { border-color: #4A148C; }
    .header-r-mt { background: linear-gradient(135deg, #6A1B9A, #4A148C); } /* å¾©å¾Œç¶­æŒ: æ·±ç´« */

    .sub-block {
        margin: 2px 4px; padding: 4px; border-radius: 6px; 
        background: #F8F9FA; border-left: 5px solid #455A64;
    }
    .sub-block-title {
        font-size: 14px; font-weight: 900; color: #263238;
        margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
    }

    /* æŒ‰éˆ•æ¨£å¼ï¼šæ·±é»‘è‰²åŠ ç²— (#1A1A1A) */
    .stPopover button { 
        font-weight: 900 !important; font-size: 11px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }
    .stPopover button[aria-label*="ğŸ“"] { background: #E1F5FE !important; border-left: 5px solid #0288D1 !important; } 

    .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 38px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å°èˆªæ•¸æ“šåº«ï¼šå…¨éšæ®µã€ç²¾ç¢ºåˆ†å­åˆ†å‹ã€MOC/PSOC/PROC ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "dMMR / MSI-H / MMRd", "content": "ä¸€ç·šæ¨™ç«¿ï¼šChemo + PD-1 (RUBY/GY018/AtTEnd)ã€‚"},
            {"title": "pMMR / NSMP / MSS", "content": "ä¸€ç·šè€ƒæ…® Chemo + ç¶­æŒ (DUO-E)ã€‚äºŒç·šæ¨™é¶å…ç–« (KN775)ã€‚"},
            {"title": "POLE mutation (è¶…çªè®Šå‹)", "content": "é å¾Œæ¥µä½³ã€‚æ—©æœŸå¯è€ƒæ…®æ²»ç™‚é™éš (De-escalation)ï¼Œé¿å…å¤šé¤˜æ¯’æ€§ã€‚"},
            {"title": "p53 mutation (é«˜æ‹·è²å‹)", "content": "ä¾µè¥²æ€§æœ€å¼·ã€‚å»ºè­°åŒ–æ”¾ç™‚ç©æ¥µä½µç”¨ä»‹å…¥ã€‚Serous å‹éœ€é©— HER2 (DS8201)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Maintenance Therapy", "content": "ä¸€ç·š IO æ²»ç™‚å¾Œå»¶çºŒç¶­æŒç›´åˆ°ç–¾ç—…é€²å±• (PD) (DUO-E / MK2870-033)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "Recurrent EC", "content": "æ¨™æº–äºŒç·šï¼šæ¨™é¶+å…ç–« (MSS) æˆ– IO å–®è—¥ (GARNET/MMRd/SG)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "æ•‘æ´æ²»ç™‚å¾Œç¶­æŒç•¶å‰æœ‰æ•ˆæ–¹æ¡ˆç›´è‡³ PDã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "æ‰‹è¡“ (PDS/IDS) + Carbo/Pacli Â± Bevã€‚IDS è€ƒæ…®åŠ  HIPEC (van Driel)ã€‚"},
            {"title": "Mucinous (MOC) é‘‘å®š", "content": "åˆ¤å®šï¼šCK7+/SATB2- (åŸç™¼)ã€‚Expansile (é å¾Œä½³) vs Infiltrative (æ˜“è½‰ç§»)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutation", "content": "Olaparib å–®è—¥ç¶­æŒ 2å¹´ (SOLO-1)ã€‚"}, 
            {"title": "HRD positive / BRCA wt", "content": "PAOLA-1 (Ola+Bev) æˆ– PRIMA (Nira)ã€‚"},
            {"title": "HRD negative (pHRD)", "content": "Niraparib ç¶­æŒ (PRIMA ITT) æˆ– Bevacizumabã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC (Sensitive Recur)", "content": "PFI > 6mã€‚è©•ä¼°äºŒæ¬¡æ‰‹è¡“ (DESKTOP III) æˆ–å«é‰‘è¤‡æ–¹åŒ–ç™‚ã€‚"},
            {"title": "PROC (Resistant Recur)", "content": "PFI < 6mã€‚å–®è—¥åŒ–ç™‚ Â± Bev æˆ–æ¨™é¶ ADC (MIRASOL/FRAmework)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "PARPi Maint", "content": "æ•‘æ´ç·©è§£å¾ŒçºŒç”¨ PARPi (NOVA/ARIEL3/SOLO2)ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Locally Advanced (CCRT)", "content": "åŒæ­¥åŒ–æ”¾ç™‚ Â± åŒæ­¥ IO (A18) æˆ– èª˜å°åŒ–ç™‚ (INTERLACE/CALLA)ã€‚"},
            {"title": "Early Stage (Surgery)", "content": "æ ¹æ²»è¡“ (LACC) æˆ–å–®ç´”åˆ‡é™¤ (SHAPE)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Maintenance Therapy", "content": "ä¸€ç·šè½‰ç§»æ€§æ–¹æ¡ˆå¾ŒçºŒç”¨ IO ç¶­æŒ (KEYNOTE-826)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "Recurr / Metastatic", "content": "ä¸€ç·š Pembro+åŒ–ç™‚Â±Bev (KN826) æˆ– Atezoçµ„åˆ (BEATcc)ã€‚äºŒç·š ADC (innovaTV)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ•‘æ´æ–¹æ¡ˆç›´è‡³é€²å±•ã€‚"}]}
    ]
}

# --- 2. æ¥µé‡åŒ–è³‡æ–™åº«ï¼š33 é …è©¦é©—æ·±åº¦æ•¸æ“š (Milestones & Ongoing) ---
all_trials_db = [
    # === Endometrial Milestones ===
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H / MMRd"], "name": "ğŸ“š RUBY (ENGOT-EN6)", "pharma": "GSK", "drug": "Dostarlimab + Carboplatin/Paclitaxel", 
     "results": "dMMR: HR 0.32; mOS 44.6m (vs 28.2m, HR 0.69)ã€‚", 
     "rationale": "PD-1 æŠ‘åˆ¶åŠ‘èˆ‡å«é‰‘åŒ–ç™‚å…·å‚™å”åŒ ICD æ•ˆæ‡‰ï¼Œé‡‹æ”¾å…ç–«å¾®ç’°å¢ƒå£“åŠ›ä¸¦é‡å° MMRd æ‚£è€…é”åˆ°æŒä¹…æ‡‰ç­” (Durable Response)ã€‚",
     "regimen": "Dostarlimab 500mg Q3W + Carboplatin/Paclitaxel x6 é€±æœŸ -> ç¶­æŒæœŸ Dostarlimab 1000mg Q6W æœ€é•· 3å¹´ã€‚",
     "inclusion": ["æ–°è¨ºæ–· Stage III-IV æˆ–é¦–æ¬¡å¾©ç™¼ä¹‹å­å®®å…§è†œç™Œ (EC)ã€‚", "åŒ…å« Carcinosarcoma çµ„ç¹”å‹æ…‹ã€‚"],
     "exclusion": ["å…ˆå‰æ¥å—éç³»çµ±æŠ—ç™Œæ²»ç™‚ã€‚", "æ´»å‹•æ€§è‡ªé«”å…ç–«ç–¾ç—…ã€‚"],
     "outcomes": "dMMR æ—ç¾¤ PFS HR 0.32 (95% CI, 0.17-0.63); mOS 44.6m (vs 28.2m, HR 0.69)."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H / MMRd", "pMMR / NSMP / MSS"], "name": "ğŸ“š NRG-GY018", "pharma": "MSD", "drug": "Pembrolizumab + Carboplatin/Paclitaxel", 
     "results": "dMMR PFS HR 0.30; pMMR HR 0.54.", 
     "rationale": "é€éåŒ–ç™‚èª˜å°è…«ç˜¤æŠ—åŸé‡‹æ”¾ï¼ŒPembrolizumab å¼·åŒ–ä¸€ç·šæ²»ç™‚ä¸è«– MMR ç‹€æ…‹ä¹‹ç”Ÿå­˜ç²ç›Šã€‚",
     "regimen": "Pembrolizumab 200mg Q3W + CP x6 é€±æœŸ -> ç¶­æŒ 400mg Q6W x2å¹´ã€‚",
     "outcomes": "dMMR PFS HR 0.30 (95% CI 0.19-0.48); pMMR PFS HR 0.54 (95% CI 0.41-0.71)."},

    {"cancer": "Endometrial", "pos": "P-MT", "sub_pos": ["pMMR / NSMP / MSS"], "name": "ğŸ“š DUO-E", "pharma": "AZ", "drug": "Durvalumab + CP â†’ç¶­æŒ Â± Olaparib", 
     "results": "ä¸‰è—¥çµ„ (Durva+Ola) pMMR PFS HR 0.57 (vs CP)ã€‚", 
     "rationale": "æ¢ç´¢ PARP æŠ‘åˆ¶åŠ‘åœ¨ pMMR æ—ç¾¤å…ç–«ç¶­æŒéšæ®µçš„å”åŒå¢æ•æ•ˆæ‡‰èˆ‡ DNA ä¿®å¾©æŠ‘åˆ¶åƒ¹å€¼ã€‚",
     "outcomes": "pMMR ä¸‰è—¥çµ„ (Durva+Ola) PFS HR 0.57; å–®è—¥ç¶­æŒ HR 0.77."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H / MMRd"], "name": "ğŸ“š AtTEnd (ENGOT-EN7)", "pharma": "Roche", "drug": "Atezolizumab + CP", 
     "results": "dMMR PFS HR 0.36; ITT OS HR 0.82ã€‚", 
     "rationale": "PD-L1 æŠ‘åˆ¶åŠ‘ä½µç”¨å«é‰‘åŒ–ç™‚åœ¨ä¸€ç·šæ™šæœŸæ‚£è€…ä¹‹ç”Ÿå­˜å„ªå‹¢é©—è­‰ã€‚",
     "outcomes": "dMMR PFS HR 0.36 (95% CI 0.23-0.57); mOS ITT HR 0.82."},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š KEYNOTE-775 (Study 309)", "pharma": "MSD/Eisai", "drug": "Lenvatinib + Pembrolizumab", 
     "results": "pMMR OS HR 0.68; mOS 17.4m (vs 12.0m)ã€‚",
     "rationale": "çµåˆ VEGF-TKI é‡å¡‘è¡€ç®¡ä¸¦æ¸›è¼•å…ç–«æŠ‘åˆ¶ï¼Œå…‹æœ MSS è…«ç˜¤å°å…ç–«æ²»ç™‚çš„å†·å¾®ç’°å¢ƒã€‚",
     "regimen": "Lenvatinib 20mg QD + Pembrolizumab 200mg Q3Wã€‚",
     "inclusion": ["å«é‰‘æ²»ç™‚å¾Œé€²å±•ä¹‹æ™šæœŸ ECã€‚", "ä¸é™ MMR ç‹€æ…‹ã€‚"]},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š GARNET", "pharma": "GSK", "drug": "Dostarlimab å–®è—¥", 
     "results": "dMMR ORR 45.5%; DOR æœªé”åˆ°ã€‚",
     "rationale": "å¥ å®š MSI-H/dMMR æ‚£è€…å¾Œç·šå–®è—¥å…ç–«ä¹‹äºŒç·šæ¨™æº–åœ°ä½ã€‚"},

    # === Cervical Milestones ===
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š KEYNOTE-A18", "pharma": "MSD", "drug": "Pembrolizumab + CCRT", 
     "results": "36å€‹æœˆ OS ç‡ 82.6% (HR 0.67)ã€‚", 
     "rationale": "å°‡åŒæ­¥å…ç–« (Concurrent IO) æ•´åˆå…¥é«˜é¢¨éšªå±€éƒ¨æ™šæœŸä¹‹æ ¹æ²»åŒæ­¥åŒ–æ”¾ç™‚ã€‚",
     "regimen": "Cisplatin + RT åŒæ­¥ Pembro 200mg Q3W x5 é€±æœŸ -> ç¶­æŒ 400mg Q6W æœ€é•· 15é€±æœŸã€‚"},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š INTERLACE", "pharma": "UCL", "drug": "Induction Carbo/Pacli x6 -> CCRT", 
     "results": "5å¹´ OS ç‡ 80% (vs 72%, HR 0.60)ã€‚",
     "rationale": "èª˜å°åŒ–ç™‚ (Induction) é€éè€è—¥æ–°ç”¨é¡¯è‘—æ¸›å°‘é ç«¯è½‰ç§»ä¸¦æå‡é•·æœŸå­˜æ´»ã€‚"},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š CALLA", "pharma": "AZ", "drug": "Durvalumab + CCRT", 
     "results": "æ•´é«”æœªé” PFS é¡¯è‘—æ”¹å–„ (HR 0.84)ã€‚",
     "rationale": "æ¢ç´¢åŒæ­¥ IO åŠ æ”¾åŒ–ç™‚åœ¨å±€éƒ¨æ™šæœŸå­å®®é ¸ç™Œçš„çµ„åˆæ¥µé™èˆ‡æŒ‘æˆ°ã€‚"},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š KEYNOTE-826", "pharma": "MSD", "drug": "Pembrolizumab + Chemo Â± Bev", 
     "results": "ITT OS HR 0.63; CPSâ‰¥1 HR 0.60ã€‚",
     "rationale": "ä¸€ç·šè½‰ç§»æ€§å­å®®é ¸ç™Œçš„å…ç–«çµ„åˆé»ƒé‡‘æ¨™æº–ï¼Œæ¥µå¤§åŒ–ç”Ÿå­˜ç²ç›Šã€‚",
     "outcomes": "mOS 24.4m (vs 16.5m, HR 0.63); mPFS 10.4m (vs 8.2m)."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š BEATcc (ENGOT-Cx10)", "pharma": "Roche", "drug": "Atezolizumab + Chemo + Bev", 
     "results": "PFS 13.7m vs 10.4m (HR 0.62)ã€‚",
     "rationale": "æä¾› PD-L1 æŠ‘åˆ¶åŠ‘ä½µç”¨æŠ—è¡€ç®¡æ–°ç”Ÿè—¥ç‰©åœ¨ä¸€ç·šè½‰ç§»æ€§æ‚£è€…ä¹‹ç”Ÿå­˜é©—è­‰ã€‚"},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š EMPOWER-Cervical 1", "pharma": "Regeneron", "drug": "Cemiplimab", 
     "results": "OS HR 0.69; mOS 12.0m vs 8.5mã€‚",
     "rationale": "äºŒç·šå¾Œå–®è—¥å…ç–«ä¹‹ OS åŸºçŸ³ç ”ç©¶ï¼Œè­‰æ˜ç”Ÿå­˜ç²ç›Šä¸ä¾è³´åˆ†å‹ã€‚"},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š innovaTV 301 (ENGOT-cx12)", "pharma": "Genmab", "drug": "Tisotumab Vedotin (ADC)", 
     "results": "OS HR 0.70; ORR 17.8%ã€‚",
     "rationale": "æ¨™é¶çµ„ç¹”å› å­ (TF) ADCï¼Œè§£æ±ºå¾Œç·šåŒ–ç™‚è€è—¥æ€§ç“¶é ¸ï¼Œé¦–å€‹ OS ç²ç›Šä¹‹ CC ADCã€‚"},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early Stage (Surgery)"], "name": "ğŸ“š SHAPE trial", "pharma": "CCTG", "drug": "Simple Hysterectomy", 
     "results": "3å¹´ç›†è…”å¾©ç™¼ç‡ 2.5% vs 2.2% (HR 1.0)ã€‚",
     "rationale": "æ”¯æŒä½é¢¨éšªæ—©æœŸæ‚£è€…é€²è¡Œæ‰‹è¡“é™éš (De-escalation) ä»¥é™ä½ä½µç™¼ç—‡ã€‚"},

    # === Ovarian Milestones ===
    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutation"], "name": "ğŸ“š SOLO-1", "pharma": "AZ", "drug": "Olaparib Maint", 
     "results": "7å¹´å­˜æ´»ç‡ 67% (HR 0.33)ã€‚",
     "rationale": "åˆ©ç”¨ PARP æŠ‘åˆ¶åŠ‘åˆæˆè‡´æ­» (Synthetic Lethality) æ©Ÿåˆ¶å»¶ç·©ä¸€ç·šå¾©ç™¼æ™‚é–“ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt", "HRD negative"], "name": "ğŸ“š PRIMA (ENGOT-OV26)", "pharma": "GSK", "drug": "Niraparib Maint", 
     "results": "HRD+ PFS HR 0.43; å…¨äººç¾¤ HR 0.62ã€‚",
     "rationale": "é¦–å€‹è­‰æ˜ä¸é™ BRCA ä¹‹ PARPi ä¸€ç·šå…¨äººç¾¤ç¶­æŒç²ç›Šçš„ç ”ç©¶ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt"], "name": "ğŸ“š PAOLA-1 (ENGOT-ov25)", "pharma": "AZ", "drug": "Olaparib + Bevacizumab", 
     "results": "HRD+ 5å¹´ OS ç‡ 75.2% (HR 0.62)ã€‚",
     "rationale": "çµ„åˆ PARPi èˆ‡ anti-VEGF ç¶­æŒè·¯å¾‘ï¼Œå¼·åŒ– HRD+ æ‚£è€…æ²»ç™’æ½›åŠ›ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutation", "HRD positive / BRCA wt"], "name": "ğŸ“š ATHENAâ€“MONO", "pharma": "Clovis", "drug": "Rucaparib Maint", 
     "results": "ITT PFS HR 0.52 (28.7m vs 11.3m)ã€‚"},

    {"cancer": "Ovarian", "pos": "PR-Maint", "sub_pos": ["PARPi Maint"], "name": "ğŸ“š NOVA", "pharma": "GSK", "drug": "Niraparib å¾©ç™¼ç¶­æŒ", 
     "results": "gBRCA HR 0.27; non-gBRCA HR 0.45ã€‚"},

    {"cancer": "Ovarian", "pos": "PR-Maint", "sub_pos": ["PARPi Maint"], "name": "ğŸ“š ARIEL3", "pharma": "Clovis", "drug": "Rucaparib å¾©ç™¼ç¶­æŒ", 
     "results": "HRD+ PFS HR 0.32 (13.6m vs 5.4m)ã€‚"},

    {"cancer": "Ovarian", "pos": "PR-Maint", "sub_pos": ["PARPi Maint"], "name": "ğŸ“š SOLO2", "pharma": "AZ", "drug": "Olaparib å¾©ç™¼ç¶­æŒ", 
     "results": "BRCAm é•·æœŸ mOS 51.7m (vs 38.8m, HR 0.74)ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt"], "name": "ğŸ“š DUO-O", "pharma": "AZ", "drug": "Durva+Ola+Bev ç¶­æŒ", 
     "results": "HRD+ PFS HR 0.49ã€‚",
     "rationale": "æ¢ç´¢ä¸‰è—¥è¯ç”¨ (IO+PARPi+VEGF) åœ¨æ–°è¨ºæ–·æ‚£è€…ä¸­çš„ç¶­æŒå„ªå‹¢ã€‚"},

    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)"], "name": "ğŸ“š MIRASOL", "pharma": "ImmunoGen", "drug": "Mirvetuximab Soravtansine", 
     "results": "OS HR 0.67; ORR 42.3%; mOS 16.4mã€‚",
     "rationale": "FRÎ± ADC åœ¨é‰‘é¡æŠ—è—¥å‹æ‚£è€…ä¸­æœ‰ OS ç²ç›Šä¹‹æ­·å²çªç ´æ€§å¯¦è­‰ã€‚",
     "regimen": "Mirvetuximab 6.0 mg/kg (AIBW) IV Q3W ç›´è‡³é€²å±•ã€‚"},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š HIPEC (van Driel)", "pharma": "NEJM 2018", "drug": "Surgery + HIPEC", 
     "results": "mOS å»¶é•· 12 å€‹æœˆ (HR 0.67)ã€‚",
     "rationale": "é–“æ­‡æ¸›ç©æ‰‹è¡“ (IDS) æ™‚åŒæ­¥åŠ æº«åŒ–ç™‚å¼·åŒ–è…¹è†œå¾®å°ç—…ç¶æ®ºå‚·ã€‚"},

    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PSOC (Sensitive Recur)"], "name": "ğŸ“š DESKTOP III", "pharma": "NEJM 2021", "drug": "Secondary Cytoreduction", 
     "results": "å®Œå…¨åˆ‡é™¤ (R0) è€… mOS 53.7m (vs 46.0m, HR 0.75)ã€‚",
     "rationale": "åš´é¸æ‚£è€… (AGO Score+) äºŒæ¬¡æ‰‹è¡“å…·ç”Ÿå­˜ç²ç›Šã€‚"},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š LION", "pharma": "NEJM 2019", "drug": "No Lymphadenectomy", 
     "results": "è‡¨åºŠ LN é™°æ€§å…æ¸…æƒï¼šOS ç„¡å·®ç•° (HR 1.06)ã€‚"},

    # === ğŸ“ Ongoing Trials (8æ ¸å¿ƒè¨ˆç•«æ•‘æ´) ===
    {"cancer": "Ovarian", "name": "ğŸ“ FRAmework-01", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)", "PSOC (Sensitive Recur)"], "type": "Ongoing",
     "pop_summary": "FRÎ± ADC ä½µç”¨ anti-VEGFï¼šè·¨çµ„åˆ¥æå‡æ»²é€èˆ‡æ®ºå‚·åŠ›ã€‚",
     "rationale": "é€é LY4170156 (FRÎ± ADC) ç²¾æº–æ¨™é¶èˆ‡ Bevacizumab è¡€ç®¡é‡å¡‘ä½œç”¨ç”¢ç”Ÿå”åŒæ•ˆæœã€‚",
     "regimen": "LY4170156 3mg/kg IV + Bevacizumab 15mg/kg IV Q3Wã€‚",
     "inclusion": ["ç¶“æª¢æ¸¬ç¢ºèª FRÎ± è¡¨é”é™½æ€§ã€‚", "æœ€å¾Œé‰‘é¡å¾Œé€²å±•ä¹‹ PROC æˆ– PSOC (PFI > 90d)ã€‚"],
     "exclusion": ["æ›¾ç”¨é Topo I ADCã€‚", "æ´»å‹•æ€§é–“è³ªæ€§è‚ºç—… (ILD)ã€‚"]},

    {"cancer": "Ovarian", "name": "ğŸ“ REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)"], "type": "Ongoing",
     "rationale": "æ¨™é¶ CDH6 ADCï¼Œå…·æ¥µé«˜ DAR (8) å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰æŒ‘æˆ°ç•°è³ªæ€§ PROCã€‚",
     "regimen": "Raludotatug deruxtecan 5.6mg/kg IV Q3Wã€‚",
     "inclusion": ["HG Serous æˆ– Endometrioid PROCã€‚", "æä¾›åˆ‡ç‰‡åˆ¤å®š CDH6 åˆ†å±¤ã€‚"]},

    {"cancer": "Endometrial", "name": "ğŸ“ MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembrolizumab", "pos": "P-MT", "sub_pos": ["Maintenance Therapy"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1ï¼Œæ—¨åœ¨æå‡ pMMR æ—ç¾¤ä¸€ç·šç¶­æŒæ·±åº¦ã€‚",
     "regimen": "Pembrolizumab 400mg Q6W + Sac-TMT 5mg/kg Q6Wã€‚",
     "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬ç¢ºèª)ã€‚", "FIGO III/IV æœŸä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PRã€‚"]},

    {"cancer": "Endometrial", "name": "ğŸ“ GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "type": "Ongoing",
     "rationale": "é‡å° Trop-2 ADC å°æŠ—é‰‘é¡èˆ‡å…ç–«å¤±æ•—ä¹‹æ•‘æ´æ²»ç™‚ã€‚",
     "regimen": "Sacituzumab govitecan 10mg/kg (Day 1, Day 8) Q21Dã€‚",
     "inclusion": ["å¾©ç™¼æ€§ EC (ä¸å«è‚‰ç˜¤)ã€‚", "å…ˆå‰æ›¾æ¥å—éé‰‘é¡åŒ–ç™‚åŠ PD-1/L1 å¤±æ•—è€…ã€‚"]},

    {"cancer": "Ovarian", "name": "ğŸ“ DOVE", "pharma": "GSK", "drug": "Dostarlimab + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)"], "type": "Ongoing",
     "rationale": "é‡å° OCCC é€æ˜ç´°èƒç™Œåˆ©ç”¨é›™é‡é˜»æ–·æ”¹å–„å…¶ç‰¹æœ‰å…ç–«æŠ‘åˆ¶ç’°å¢ƒã€‚"},

    {"cancer": "Ovarian", "name": "ğŸ“ DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "P-MT", "sub_pos": ["BRCA / HRD path"], "type": "Ongoing",
     "rationale": "æ¨™é¶ HER2 ADC ç”¨æ–¼ä¸€ç·šç¶­æŒéšæ®µï¼Œæ¸…é™¤ HER2 è¡¨ç¾å¾®å°æ®˜ç•™ç—…ç¶ã€‚"},
]

# --- 3. AI å·¡é‚åŠŸèƒ½ ---
def get_gemini_model():
    try:
        available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
        target_model = next((m for m in available_models if 'gemini-1.5-flash' in m), None)
        if not target_model: target_model = next((m for m in available_models if 'gemini-pro' in m), None)
        if target_model: return genai.GenerativeModel(target_model)
    except: return None

# --- 4. å´é‚Šæ¬„ï¼šAI æ±ºç­–èˆ‡ç—…æ­·åˆ†æ ---
with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰åª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ æ‚£è€…ç—…æ­·æ•¸æ“šæ·±åº¦åˆ†æ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥æ‘˜è¦ (å«åˆ†æœŸ/ç´°èƒ/æ¨™è¨˜)", placeholder="ä¾‹å¦‚ï¼šEC Stage III, dMMR, p53 mutation...", height=220)
        if st.button("ğŸš€ é–‹å§‹åª’åˆåˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = get_gemini_model()
                    prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚è«‹åƒè€ƒå¯¦è­‰åº«ï¼š{all_trials_db}ã€‚å»ºè­°é©åˆè·¯å¾‘èˆ‡è©¦é©—ç†ç”±ã€‚"
                    st.write(model.generate_content(prompt).text)
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 5. ä¸»é é¢ï¼šå°èˆªåœ°åœ– ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 æ——è‰¦æ•´åˆæ•‘æ´ç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

cols = st.columns(len(guidelines_nested[cancer_type]))
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            
            # é¡¯ç¤ºå°æ‡‰è©¦é©— (ğŸ“š & ğŸ“)
            rel_trials = [t for t in all_trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                label = f"{t.get('pharma', 'N/A')} | {t['name']} | {t['drug']}"
                with st.popover(label, use_container_width=True):
                    st.success(f"**ç™‚æ•ˆæ‘˜è¦:** {t.get('results', t.get('pop_results', 'æ‹›å‹Ÿä¸­'))}")
                    unique_key = f"sync_{t['name']}_{cancer_type}_{stage['id']}_{sub['title'].replace(' ', '')}"
                    if st.button("ğŸ“Š åŒæ­¥çœ‹æ¿ç´°ç¯€", key=unique_key):
                        st.session_state.selected_trial = t['name']
                        st.rerun() # å¼·åˆ¶è¯å‹•åˆ·æ–°
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 6. æ·±åº¦æ•¸æ“šçœ‹æ¿ (Bottom Selector) ---
st.divider()
st.subheader("ğŸ“‹ è‡¨åºŠç ”ç©¶æ¥µé‡åŒ–æ•¸æ“šåº« (Published Milestones & Ongoing Trials)")
filtered_list = [t for t in all_trials_db if t["cancer"] == cancer_type]

# æ ¹æ“šç›®å‰é¸æ“‡çš„ç™Œç—‡éæ¿¾é¸é …
if not filtered_list: 
    st.info("è©²ç™Œç—‡é¡åˆ¥ä¸‹ç„¡é©ç”¨é …ç›®ã€‚")
else:
    try: curr_idx = [t["name"] for t in filtered_list].index(st.session_state.selected_trial)
    except: curr_idx = 0

    selected_name = st.selectbox("ğŸ¯ å¿«é€Ÿé¸æ“‡æˆ–åŒæ­¥åˆ‡æ›ç ”ç©¶ï¼š", [t["name"] for t in filtered_list], index=curr_idx, key="trial_selector")
    st.session_state.selected_trial = selected_name
    t_obj = next(it for it in all_trials_db if it["name"] == selected_name)

    st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
    st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t_obj['name']} æ·±åº¦åˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

    r1, r2 = st.columns([1.3, 1])
    with r1:
        st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Rationale & Regimen (æ©Ÿè½‰èˆ‡çµ¦è—¥)</b></div>", unsafe_allow_html=True)
        st.write(f"**æ ¸å¿ƒé…æ–¹:** {t_obj['drug']}")
        st.write(f"**è©³ç´°çµ¦è—¥æ–¹æ¡ˆ (Regimen Details):** {t_obj.get('regimen', 'è©³è¦‹ Protocol å…·é«”è¦å®šã€‚')}")
        st.success(f"**ç§‘å­¸ç†æ“š (Scientific Rationale):** {t_obj.get('rationale', 'æ—¨åœ¨æŒ‘æˆ°ç¾æœ‰ SoC ç“¶é ¸ï¼Œæå‡ç”Ÿå­˜ç²ç›Šã€‚')}")

    with r2:
        st.markdown("<div style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Key Outcomes (ç”Ÿå­˜èˆ‡ç·©è§£æ•¸æ“š)</b></div>", unsafe_allow_html=True)
        st.markdown(f"""
            <div style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
                <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Survival Metrics (PFS/OS/HR/ORR)</div>
                <div class='hr-big-val'>{t_obj.get('results', t_obj.get('outcomes', 'Ongoing Recruitment'))}</div>
            </div>
        """, unsafe_allow_html=True)

    st.divider()
    r3, r4 = st.columns(2)
    with r3:
        st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (é—œéµç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for inc in t_obj.get('inclusion', ['ç¬¦åˆç‰¹å®šåˆ†å­åˆ†å‹ã€‚']): st.write(f"â€¢ **{inc}**")
    with r4:
        st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (é—œéµæ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for exc in t_obj.get('exclusion', ['æ’é™¤æ´»å‹•æ€§ç–¾ç—…æˆ–é‡å¤§åŠŸèƒ½ä¸å…¨ã€‚']): st.write(f"â€¢ **{exc}**")
    st.markdown("</div>", unsafe_allow_html=True)
